CIQ

Based on 8 reference(s) in Google Scholar 8 10 8

Axon 4169

CAS [486427-17-2]

MF C26H26ClNO5
MW 467.94

  • Purity: 99%
  • Soluble in DMSO and EtOH

CIQ

Description

CIQ is a first NMDA receptor-positive allosteric modulator with subunit-selectivity for NR2C and NR2D (EC50 values of 2.7 and 2.8 μM for NR2C and NR2D, respectively).

Keywords: CIQ | Supplier | NR2C/NR2D PAM | CAS [486427-17-2] | Glutamate | NMDA | PAM | Ion Channels | Alzheimer's disease | Parkinson's disease | Depression | Schizophrenia | Epilepsy | iGluR | Potentiator | GluN2C | GluN2D

First NMDA NR2C/NR2D PAM

Chemical name

(3-Chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone

Parent CAS No.

[486427-17-2]

Order
Size Unit Price Stock
10 mg €130.00 In Stock
50 mg €470.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...